These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 8644646)
1. Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing. Stambler BS; Wood MA; Ellenbogen KA Am J Cardiol; 1996 May; 77(11):960-6. PubMed ID: 8644646 [TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy. Stambler BS; Wood MA; Ellenbogen KA Circulation; 1997 Dec; 96(12):4298-306. PubMed ID: 9416896 [TBL] [Abstract][Full Text] [Related]
3. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. Volgman AS; Carberry PA; Stambler B; Lewis WR; Dunn GH; Perry KT; Vanderlugt JT; Kowey PR J Am Coll Cardiol; 1998 May; 31(6):1414-9. PubMed ID: 9581743 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of ibutilide for termination of atrial fibrillation and flutter. Ellenbogen KA; Clemo HF; Stambler BS; Wood MA; VanderLugt JT Am J Cardiol; 1996 Oct; 78(8A):42-5. PubMed ID: 8903275 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study. Ellenbogen KA; Stambler BS; Wood MA; Sager PT; Wesley RC; Meissner MC; Zoble RG; Wakefield LK; Perry KT; Vanderlugt JT J Am Coll Cardiol; 1996 Jul; 28(1):130-6. PubMed ID: 8752805 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects on drug concentrations, electrophysiologic parameters, and termination of atrial fibrillation in dogs when procainamide and ibutilide are delivered into the right atrium versus intravenously. Vereckei A; Warman E; Mehra R; Zipes DP J Cardiovasc Electrophysiol; 2001 Mar; 12(3):330-6. PubMed ID: 11291807 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Stambler BS; Wood MA; Ellenbogen KA; Perry KT; Wakefield LK; VanderLugt JT Circulation; 1996 Oct; 94(7):1613-21. PubMed ID: 8840852 [TBL] [Abstract][Full Text] [Related]
8. Conversion of atrial flutter by ibutilide is associated with increased atrial cycle length variability. Guo GB; Ellenbogen KA; Wood MA; Stambler BS J Am Coll Cardiol; 1996 Apr; 27(5):1083-9. PubMed ID: 8609325 [TBL] [Abstract][Full Text] [Related]
9. Facilitating influence of procainamide on conversion of atrial flutter by rapid atrial pacing. Heisel A; Jung J; Stopp M; Schieffer H Eur Heart J; 1997 May; 18(5):866-9. PubMed ID: 9152658 [TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic and electrophysiologic effects of intravenous ibutilide and sotalol in the canine sterile pericarditis model. Buchanan LV; LeMay RJ; Walters RR; Hsu CY; Brunden MN; Gibson JK J Cardiovasc Electrophysiol; 1996 Feb; 7(2):113-9. PubMed ID: 8853021 [TBL] [Abstract][Full Text] [Related]
11. Use of procainamide with rapid atrial pacing for successful conversion of atrial flutter to sinus rhythm. Olshansky B; Okumura K; Hess PG; Henthorn RW; Waldo AL J Am Coll Cardiol; 1988 Feb; 11(2):359-64. PubMed ID: 3339174 [TBL] [Abstract][Full Text] [Related]
12. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group. Vos MA; Golitsyn SR; Stangl K; Ruda MY; Van Wijk LV; Harry JD; Perry KT; Touboul P; Steinbeck G; Wellens HJ Heart; 1998 Jun; 79(6):568-75. PubMed ID: 10078083 [TBL] [Abstract][Full Text] [Related]
13. Clinical comparison of ibutilide and propafenone for converting atrial flutter. Sun JL; Guo JH; Zhang N; Zhang HC; Zhang P Cardiovasc Drugs Ther; 2005 Jan; 19(1):57-64. PubMed ID: 15883757 [TBL] [Abstract][Full Text] [Related]
14. Prevention of acute inducible atrial flutter in dogs by using an ibutilide-polymer-coated pacing electrode. Labhasetwar V; Strickberger SA; Underwood T; Davis J; Levy RJ J Cardiovasc Pharmacol; 1998 Mar; 31(3):449-55. PubMed ID: 9514191 [TBL] [Abstract][Full Text] [Related]
15. Acute management of atrial fibrillation and atrial flutter in the critical care unit: should it be ibutilide? Varriale P; Sedighi A Clin Cardiol; 2000 Apr; 23(4):265-8. PubMed ID: 10763074 [TBL] [Abstract][Full Text] [Related]
16. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed. Hennersdorf MG; Perings SM; Zühlke C; Heidland UE; Perings C; Heintzen MP; Strauer BE Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531 [TBL] [Abstract][Full Text] [Related]
17. Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter. Howard PA Ann Pharmacother; 1999 Jan; 33(1):38-47. PubMed ID: 9972384 [TBL] [Abstract][Full Text] [Related]
18. Ibutilide. A review of its pharmacological properties and clinical potential in the acute management of atrial flutter and fibrillation. Foster RH; Wilde MI; Markham A Drugs; 1997 Aug; 54(2):312-30. PubMed ID: 9257085 [TBL] [Abstract][Full Text] [Related]
19. Transitions among atrial fibrillation, atrial flutter, and sinus rhythm during procainamide infusion and vagal stimulation in dogs with sterile pericarditis. Pagé PL; Hassanalizadeh H; Cardinal R Can J Physiol Pharmacol; 1991 Jan; 69(1):15-24. PubMed ID: 2036596 [TBL] [Abstract][Full Text] [Related]
20. Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation. Study Investigators. Abi-Mansour P; Carberry PA; McCowan RJ; Henthorn RW; Dunn GH; Perry KT Am Heart J; 1998 Oct; 136(4 Pt 1):632-42. PubMed ID: 9778066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]